Annual Statements Open main menu

Cosmos Health Inc. - Quarter Report: 2014 September (Form 10-Q)

 

 

UNITED STATES 

SECURITIES AND EXCHANGE COMMISSION 

Washington, D.C. 20549

 

FORM 10-Q

 

x QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended September 30, 2014

 

OR

 

¨ TRANSITION REPORT UNDERSECTION 13 OR 15(d) OF THE EXCHANGE ACT

 

For the transition period from ___________ to ___________

 

Commission file number: 000-54436

 

COSMOS HOLDINGS INC.

(Exact name of registrant as specified in its charter)

  

Nevada

 

27-0611758

(State or other jurisdiction of incorporation or organization)

 

(I.R.S. Employer Identification No.)

     

141 West Jackson Blvd, Suite

4236, Chicago, Illinois

 

60604

(Address of principal executive offices)

 

(Zip Code)

  

Registrant’s telephone number: (312) 674.4529

 

N/A 

(Former name, former address and former three months, if changed since last report)

 

Check whether the issuer (1) filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the past 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes  x No ¨

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yesx No ¨

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of "large accelerated filer," "accelerated filer" and "smaller reporting company" in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer

¨

Accelerated filer

¨

Non-accelerated filer

¨

Smaller Reporting Company

x

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes  ¨ No  x

 

As of November 13, 2014 there were 125,585,532 shares issued and outstanding of the registrant’s common stock. 

 

 

 

COSMOS HOLDINGS INC.

 

TABLE OF CONTENTS

 

PART I – FINANCIAL INFORMATION

       
           

Item 1.

Financial Statements.

 

F-1

 
           

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations.

   

3

 
           

Item 3.

Quantitative and Qualitative Disclosure about Market Risk.

   

8

 
           

Item 4.

Controls and Procedures.

   

8

 
           

PART II – OTHER INFORMATION

       
           

Item 1.

Legal Proceedings.

   

9

 
           

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds.

   

9

 
           

Item 3.

Defaults Upon Senior Securities.

   

9

 
           

Item 4.

Mine Safety Disclosures.

   

9

 
           

Item 5.

Other Information.

   

9

 
           

Item 6.

Exhibits.

   

10

 
           

SIGNATURES

 

   

11

 

 

 
2

 

PART I – FINANCIAL INFORMATION

 

ITEM 1 – FINANCIAL STATEMENTS

 

COSMOS HOLDINGS INC

CONDENSED CONSOLIDATED BALANCE SHEETS

(unaudited)

 

  September 30,
2014
    December 31,
2013
 

ASSETS

Cash and equivalents

 

$

84,425

   

$

864,489

 

Accounts receivable

   

62,030

     

-

 

Prepaid expenses

   

39,774

     

435

 

Deposits

   

7,027,490

     

-

 

Other assets

   

6,756

     

2,126

 
               

TOTAL ASSETS

 

$

7,220,475

   

$

867,050

 
               

LIABILITIES AND SHAREHOLDERS’ EQUITY

               

CURRENT LIABILITIES

               

Accounts payable and accrued expenses

 

$

81,605

   

$

530,185

 

Unearned revenues

   

-

     

671

 

Salaries payable

   

179,092

     

186,592

 

Notes payable, related party

   

165,000

     

165,000

 

Taxes payable

   

1,099,965

     

38,286

 
               

TOTAL CURRENT LIABILITIES

 

$

1,525,662

   

$

920,734

 
               

SHAREHOLDERS' EQUITY

               

Preferred stock, par value $0.001, authorized 100 million shares,

    none issued and outstanding at September 30, 2014.

   

-

     

-

 

Common stock, par value $0.001, authorized 300 million, 125,585,532 and 125,585,532 issued

    and outstanding at September 30, 2014 and December 31, 2013, respectively.

   

125,586

     

125,586

 

Additional paid-in capital

 

(425,188

)

 

(432,593

)

Accumulated other comprehensive (loss) income

 

(539,525

)

   

11,319

 

Retained earnings

   

6,533,940

     

242,004

 

TOTAL SHAREHOLDERS' EQUITY (DEFICIT)

   

5,694,813

   

(53,684

)

               

TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY

 

$

7,220,475

   

$

867,050

 

 

The accompanying notes are an integral part of the unaudited condensed consolidated financial statements.

 

 
F-1

 

COSMOS HOLDINGS INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(unaudited)

 

    Nine Months Ended
September 30,
    Three Months Ended
September 30,
 
   

2014

   

2013

   

2014

   

2013

 

Revenues

                       

Revenues

 

$

7,794,216

   

$

-

   

$

5,778,993

   

$

-

 
                                 

Expenses

                               

Direct consulting costs

 

 

3,017

 

 

 

552,835

 

 

 

3,017

 

 

 

63,011

 

General and administrative expenses

   

431,155

     

20,225

     

189,721

     

16,330

 

Net operating income (loss)

   

7,360,044

     

(573,060

)

   

5,586,255

     

(79,341

)

                                 

Other income and (expense)

                               

Interest expense

 

 

(63,520

)

 

 

(421

)

 

 

(63,520

)

 

 

(421

)

Interest expense - related party

   

(7,405

)

   

(72

)

   

(2,495

)

   

(72

)

Total other income and (expense)

   

(70,925

)

   

(493

)

   

(66,015

)

   

(493

)

                                 

Income (loss) before income taxes

   

7,289,119

     

(573,553

)

   

5,520,240

     

(79,834

)

                                 

Income tax expense

   

997,183

     

-

     

770,803

     

-

 
                                 

Net income (loss)

   

6,291,936

     

(573,553

)

   

4,749,437

     

(79,834

)

                                 

Other comprehensive income (loss)

                               

Unrealized foreign currency income (loss)

   

(550,844

)

   

(14,461

)

   

(483,030

)

   

(17,702

)

                                 

NET COMPREHENSIVE INCOME (LOSS)

 

$

5,741,092

   

$

(588,014

)

 

$

4,266,407

   

$

(97,536

)

                                 

Net income (loss) per share – basic

 

$

0.05

   

$

(0.01

)

 

$

0.04

   

$

(0.00

)

Net income (loss) per share – dilutive

 

$

0.05

   

$

(0.01

)

 

$

0.04

   

$

(0.00

)

Weighted average number of shares outstanding – basic

   

125,585,532

     

100,282,193

     

125,585,532

     

100,634,352

 

Weighted average number of shares outstanding – dilutive

   

125,803,939

     

100,282,193

     

125,801,795

     

100,634,352

 

 

The accompanying notes are an integral part of the unaudited condensed consolidated financial statements.

 

 
F-2

 

COSMOS HOLDINGS INC.

CONDENSED CONSOLIDATED STATEMENT OF SHAREHOLDERS’ EQUITY (DEFICIT)

(unaudited)

 

    Common Stock, Par Value $0.001    

Additional
Paid In
Capital

    Other Comprehensive Income (loss)     Retained Earnings     Total Shareholders'  
    Shares     Amount                 Equity (Deficit)  
                                                 

Balances, December 31, 2013

   

125,585,532

   

$

125,586

   

$

(432,593

)

 

$

11,319

   

$

242,004

   

$

(53,684

)
                                                 

Imputed interest

   

-

     

-

     

7,405

     

-

     

-

     

7,405

 

Foreign currency translation effect

   

-

     

-

     

-

     

(550,844

)

   

-

     

(550,844

)

Net income

   

-

     

-

     

-

     

-

     

6,291,936

     

6,291,936

 
                                                 

Balances, September 30, 2014

   

125,585,532

   

$

125,586

   

$

(425,188

)

 

$

(539,525

)

 

$

6,533,940

   

$

5,694,813

 

 

The accompanying notes are an integral part of the unaudited condensed consolidated financial statements.

 

 
F-3

 

COSMOS HOLDINGS INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(unaudited)

 

 

Nine Months Ended
September 30,

 
 

2014

   

2013

 

CASH FLOWS FROM OPERATING ACTIVITIES

         

Net income (loss)

 

$

6,291,936

   

$

(573,553

)

                 

Adjustments to reconcile net income (loss) with cash used in operations:

Imputed interest

   

7,405

     

-

 

Change in operating assets and liabilities:

               

Accounts receivable

   

(62,030

)

   

-

 

Prepaid expenses

 

 

(39,339

)

 

 

-

 

Other assets

   

(4,630

)

   

-

 

Accounts payable and accrued liabilities

   

(456,080

   

570,843

 

Taxes payable

   

1,061,679

     

-

 

Deferred revenue

   

(671

)

   

500,240

 
                 

Net cash provided by operating activities

   

6,798,270

     

497,530

 
                 

CASH FLOWS FROM FINANCING ACTIVITIES

               

Deposits

 

 

(7,027,490

)

 

 

-

 

Cash acquired upon reverse merger

   

-

     

18,148

 

Net cash provided by and (used in) financing activities

   

(7,027,490

   

18,148

 
                 

Foreign currency translation effect

   

(550,844

   

(14,461

)

                 

NET (DECREASE) and INCREASE IN CASH

   

(780,064

   

501,217

 
                 

Cash at beginning of period

   

864,489

     

-

 

Cash at end of period

 

$

84,425

   

$

501,217

 
                 

SUPPLEMENTAL DISCLOSURES

               

Cash paid for interest

 

$

-

   

$

-

 

Cash paid for income taxes

   

-

     

-

 

 

 

 

 

 

 

 

 

 

SUPPLEMENTAL DISCLOSURES OF NON-CASH FINANCING ACTIVITY

 

 

 

 

 

 

 

 

Liabilities assumed in reverse merger, net of cash acquired

 

$

-

 

 

$

313,514

 

 

The accompanying notes are an integral part of the unaudited condensed consolidated financial statements.

 

 
F-4

 

COSMOS HOLDINGS INC.

Notes to Unaudited Condensed Consolidated Financial Statements

September 30, 2014

 

NOTE 1 – BASIS OF PRESENTATION

 

The terms “COSM,” “we,” “the Company,” and “us” as used in this report refer to Cosmos Holdings Inc. The accompanying unaudited condensed consolidated balance sheet as of September 30, 2014 and unaudited condensed consolidated statements of operations for the nine and three months ended September 30, 2014 and 2013 have been prepared in accordance with generally accepted accounting principles for interim financial information and with the instructions to Form 10-Q and Article 8 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. generally accepted accounting principles for complete financial statements. In the opinion of management of COSM, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the nine and three month periods ended September 30, 2014, are not necessarily indicative of the results that may be expected for the year ending December 31, 2014, or any other period. These unaudited condensed consolidated financial statements and notes should be read in conjunction with the financial statements for each of the two years ended December 31, 2013 and 2012, included in the Company’s Annual Report on Form 10-K. The accompanying unaudited condensed consolidated balance sheet as of December 31, 2013, has been derived from the audited financial statements filed in our Form 10-K and is included for comparison purposes in the accompanying balance sheet. Certain prior year amounts have been reclassified to conform to current year presentation.

 

NOTE 2 – INCOME TAXES

 

The Company’s effective tax rate differs from the U.S. federal statutory rate primarily due to earnings taxed at the lower foreign tax rate in Cyprus. Our wholly-owned Cypriot subsidiary, Amplerissimo, has taxable income in Cyprus, where the statutory corporate income tax rate is 12.5%.

 

Prior to the acquisition of Amplerissimo, the Company had net operating losses in the U.S. which, although offset by a valuation allowance due to the uncertainty of profitable operations in the future, were available to be applied to future taxable income (if any). However, the Internal Revenue Code (“IRC”) Section 382 limits the amount of net operating loss carry-forwards that can be utilized upon a change in control. Future tax benefits of net operating loss carryforwards generated in the U.S. by the Company represent the primary component of the Company’s deferred tax assets. Under Accounting Standards Codification (“ASC”) 740 “Accounting for Income Taxes”, the Company evaluates at every reporting period whether the benefit of such losses will more likely than not be realized. Based on the Company’s history of taxable losses in the U.S. and the potential annual limitation on future utilization if it is determined that a change in ownership as defined in IRC 382 has occurred, the Company has determined that it is not more likely than not that the tax benefit of such losses will be realized prior to their expiration. At September 30, 2014, the Company had maintained a full valuation allowance against its net deferred tax assets.

 

The Company applied the “more-likely-than-not” recognition threshold to all tax positions taken or expected to be taken in a tax return, which resulted in no unrecognized tax benefits as of September 30, 2014.

 

 
F-5

 

The Company has elected to classify interest and penalties that would accrue according to the provisions of relevant tax law as interest and other expense, respectively.

 

The Company’s tax years since inception through 2014 remain open to examination by most taxing authorities.

 

The Company’s foreign subsidiary Amplerissimo recognized significant earnings in the third quarter, of which € 5,540,000 ($7,027,490) has been paid in connection with a pending acquisition as described in Note 6. As such, the Company is asserting its position under ASC 740-30-25-17

 

that the investment in its foreign subsidiary is essentially permanent in duration. No deferred tax liability has been recorded on the outside basis difference of the foreign subsidiary primarily driven by Amplerissimo’s cumulative earnings of $7,645,531.

 

NOTE 3 – RELATED PARTY TRANSACTIONS

 

At September 30, 2014, we owed $165,000 to GreenEra, Ltd., a company in which our former Chief Executive Officer and Director, Mr. Panagiotis Drakopoulos is a shareholder.

 

At September 30, 2014, our former Chief Executive Officer and Director, Mr. Panagiotis Drakopoulos, is owed $102,500 in unpaid salary.

 

Additionally, we owe $76,592 to Mr. Mavrogiannis, our former Chief Financial Officer in unpaid salary.

 

We believe that all related party transactions were on terms at least as favorable as we would have secured in arm’s-length transactions with third parties. Except as set forth above, we have not entered into any material transactions with any director, executive officer, and promoter, beneficial owner of five percent or more of our common stock, or family members of such persons.

 

NOTE 4 – LEASES

 

The Company conducts its operations from an office located in Chicago, Illinois for which we paid rent of approximately $307 per month through November 2013. In December 2013 we moved our office to another location in Chicago Illinois. Beginning in February 2014, we paid rent of approximately $709 per month for our office. Rent expense for the nine and three month periods ended September 30, 2014 was $8,696 and $2,895, respectively, and $2,473 and $926 for the nine and three month periods ended September 30, 2013, respectively.

 

 
F-6

 

NOTE 5 – EARNINGS PER SHARE

 

Basic net income (loss) per share is computed by dividing net income (loss) attributable to the Company, decreased with respect to net income or increased with respect to net loss by dividends declared on preferred stock by using the weighted-average number of common shares outstanding. The dilutive effect of incremental common shares potentially issuable under outstanding options, warrants and restricted shares is included in diluted earnings per share utilizing the treasury stock method. The computations of basic and diluted per share data were as follows:

 

    Nine Months Ended     Three Months Ended  
    September 30,
2014
    September 30,
2013
    September 30,
2014
    September 30,
2013
 

 

 

 

 

 

 

 

 

 

 

 

Net income (loss)

 

$

6,291,936

 

$

 

(573,553

)

 

$

4,749,437

   

$

(79,834

)

Weighted average common shares outstanding - basic

   

125,585,532

     

100,282,193

     

125,585,532

     

100,634,352

 

Option awards

   

218,407

     

-

     

216,263

     

-

 

Weighted average common shares outstanding - dilutive

   

125,803,939

     

100,282,193

     

125,801,795

     

100,634,352

 

Net income (loss) per share - basic and diluted

   

0.05

     

(0.01

)

   

0.04

     

(0.00

)

 

NOTE 6 – DEPOSIT ON PENDING ACQUISITION

 

On August 19, 2014, Amplerissimo entered into a Share Purchase Agreement (the "Purchase Agreement") with B2IN S.A., a corporation organized under the laws of Greece ("B2IN"), Unilog Logistics S.A., a corporation organized under the laws of Greece and a wholly owned subsidiary of B2IN ("Unilog"), and Wilot Limited, a corporation organized under the laws of Cyprus ("Seller"). Subject to the terms, conditions, and provisions of the Purchase Agreement, at the closing (the "Closing") of the transactions contemplated by the Purchase Agreement, Amplerissimo will acquire from Seller all of the outstanding capital stock of B2IN for a purchase price of seven million euros (€ 7.000.000) or approximately $8,879,500.  €5,540,000 ($7,027,490) of this purchase price was paid to the Seller by Amplerissimo as of September 30, 2014, and is classified as Deposit on the Balance Sheet.  Upon the occurrence of the Closing, Unilog will be an indirect, wholly owned subsidiary of Amplerissimo. Unilog operates a pharmaceutical logistics business in Greece.  The Closing is subject to conditions outside the control of Amplerissimo.  If the Closing does not occur for any reason, Amplerissimo is entitled to have the Deposit returned to it by Seller.

 

NOTE 7 – REVENUE RECOGNITION

We consider revenue recognizable when persuasive evidence of an arrangement exists, the price is fixed or determinable, goods or services have been delivered, and collectability is reasonably assured. These criteria are assumed to have been met if a customer orders an item, the goods or services have been shipped or delivered to the customer, and we have sufficient evidence of collectability, such a payment history with the customer. Revenue that is billed and received in advance such as recurring weekly or monthly services are initially deferred and recognized as revenue over the period the services are provided.

Our records at September 30, 2014 have been sufficient to satisfy all of the four requirements. Revenue has been recognized for the all amounts billed prior to September 30, 2014, all of which were in respect of services rendered during or prior to July 2013.

 

 
F-7


ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.
 

Forward-Looking Statements

 

Certain statements, other than purely historical information, including estimates, projections, statements relating to our business plans, objectives, and expected operating results, and the assumptions upon which those statements are based, are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements generally are identified by the words “believes,” “project,” “expects,” “anticipates,” “estimates,” “intends,” “strategy,” “plan,” “may,” “will,” “would,” “will be,” “will continue,” “will likely result,” and similar expressions. We intend such forward-looking statements to be covered by the safe-harbor provisions for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995, and are including this statement for purposes of complying with those safe-harbor provisions. Forward-looking statements are based on current expectations and assumptions that are subject to risks and uncertainties which may cause actual results to differ materially from the forward-looking statements. Our ability to predict results or the actual effect of future plans or strategies is inherently uncertain. Factors which could have a material adverse effect on our operations and future prospects on a condensed consolidated basis include, but are not limited to: changes in economic conditions, legislative/regulatory changes, availability of capital, interest rates, competition, and generally accepted accounting principles. These risks and uncertainties should also be considered in evaluating forward-looking statements and undue reliance should not be placed on such statements. We undertake no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise. Further information concerning our business, including additional factors that could materially affect our financial results, is included herein and in our other filings with the Securities and Exchange Commission (“SEC”).

 

Overview

 

We were incorporated under the name Prime Estates and Developments, Inc. in the State of Nevada on July 21, 2009 for the purpose of acquiring and operating commercial real estate and real estate related assets. On November 14, 2013, we changed our name to Cosmos Holdings Inc.

 

On September 27, 2013, we closed a reverse take-over transaction by which we acquired a private company whose principal activities are the trading of products, providing representation, and provision of consulting services to various sectors as described below. Pursuant to a Share Exchange Agreement between us and Amplerissimo Ltd, ("Amplerissimo"), a company incorporated in Cyprus and Dimitrios Goulielmos, sole shareholder of Amplerissimo, we acquired 100% of Amplerissimo’s issued and outstanding common stock.

 

We are currently focusing our existing operations on the business of our new subsidiary, Amplerissimo, and have transitioned to becoming a holding company. In that connection, the Company is currently actively looking for potential acquisition candidates in various industries. On August 19, 2014, Amplerissimo entered into a Share Purchase Agreement (the “Purchase Agreement”) with B2IN S.A., a corporation organized under the laws of Greece ("B2IN"), Unilog Logistics S.A., a corporation organized under the laws of Greece (“Unilog”) and a wholly owned subsidiary of B2IN, and Wilot Limited, a corporation organized under the laws of Cyprus (the “Seller”). Subject to the terms, conditions, and provisions of the Purchase Agreement, at the closing of the transactions (the “Closing”) contemplated by the Purchase Agreement, Amplerissimo will acquire from Seller all of the outstanding capital stock of B2IN for a purchase price of seven million euros (€ 7.000.000) or approximately $8,879,500 . €5,540,000 ($7,027,490) of the purchase price (the “Deposit”) has been paid to Seller as of September 30, 2014. The Company expects to raise the remainder of the funds through the issuance of debt or equity securities, although there can be no assurance we will be able to do so on favorable terms or at all. Upon the occurrence of the Closing, Unilog will be an indirect, wholly owned subsidiary of Amplerissimo. Unilog operates a pharmaceutical logistics business in Greece. The Closing is subject to conditions outside the control of Amplerissimo. If the Closing does not occur for any reason, Amplerissimo is entitled to have the Deposit returned to it by Seller.

 

 
3

  

We plan on continuing to offer the same products and services through Amplerissimo which include: data mining, statistical data analysis, research and analysis, negotiating services, credit risk analysis, credit management, conducting case studies, introduction services, e-commerce consulting, marketing management consulting, expansion strategies consulting, information systems consulting, and business management software consulting. We also intend to add additional services to the ones that we currently offer, including systems integration, accredited partnership services, and installation and resale of third parties systems and software. We intend to accomplish this by entering into new cooperative agreements or acquiring other existing companies but there can be no assurance we will do so. However, at this time we have no binding agreement, commitment or obligation for any such ventures. Amplerissimo has not provided services pursuant to customer engagements subsequent to July 2013 and our revenues for the current reporting period are attributable to services rendered by Amplerissimo during or prior to July 2013 as described herein.

 

We are seeking to enter the pharmaceutical sector if and when in the future we have sufficient capital through new wholly-owned subsidiaries that will focus on wholesale sales of pharmaceutical products in the European Union countries. On April 30, 2014, we entered into an Exclusive Cooperation Agreement (the “Agreement”) with Grigorios Siokas to assume the position of Manager of Pharmaceutical Division of the Company. On August 1, 2014, we, through our Cypriot subsidiary Amplerissmo, formed Sky Pharm S.A. Greek corporation (“SkyPharm”), a new subsidiary that will focus on wholesale sales of pharmaceutical products. SkyPharm is currently in the process of obtaining the necessary licensing from National Organization for Medicines required to be a wholesaler of pharmaceutical products in the European Union countries. SkyPharm has not raised any capital and otherwise does not have the capital resources necessary to commence this line of business. There can be no assurance that we will ever raise the required capital; and even if we do, there is no assurance that we will ever commence or successfully develop this line of business, notwithstanding the Agreement.

 

Results of Operations

 

Three Month Period ended September 30, 2014 versus September 30, 2013

 

For the three months ended September 30, 2013, we had general and administrative costs totaling $16,330, $63,011 in direct consulting costs associated with our projects and $0 in revenue. For the quarter ended September 30, 2014, we had revenues of $5,778,993 which was attributed to the recognition of Amplerissimo sales relating to services provided in July 2013. For the three months ended September 30, 2014, we had direct consulting costs of $3,017 associated with our projects, and general and administrative costs of $189,721, for a net operating income of $5,586,255. For the three months ended September 30, 2014 we had interest expense of $2,495 which was related to imputed interest resulting from the outstanding note with Green Era, Ltd.

 

Additionally, we had unrealized foreign currency losses of $483,030 for the three months ended September 30, 2014 such that our net comprehensive income for the period was $4,266,407.

 

Nine Month Period ended September 30, 2014 versus September 30, 2013

 

For the nine month period ended September 30, 2013, we had general and administrative costs totaling $20,225, $552,835 in direct consulting costs associated with our projects, and $0 in revenue. For the nine month period ended September 30, 2014, we had revenues of $7,794,216 which was attributed to the recognition of Amplerissimo sales relating to services provided in July 2013. For the nine months ended September 30, 2014, we had direct consulting costs of $3,017 associated with our projects, and general and administrative costs of $431,155, for a net operating income of $7,360,044. For the nine months ended September 30, 2014 we had interest expense of $7,405, which was related to imputed interest resulting from the outstanding note with Green Era, Ltd.

 

 
4

  

Additionally, we had unrealized foreign currency losses of $550,844 for the nine months ended September 30, 2014 such that our net comprehensive income for the period was $5,741,092.

 

Plan of Operation in the Next Twelve Months

 

We plan on continuing to offer the same products and services through our operating subsidiary, Amplerissimo which include: data mining, statistical data analysis, research and analysis, negotiating services, credit risk analysis, credit management, conducting case studies, introduction services, e-commerce consulting, marketing management consulting, expansion strategies consulting, information systems consulting, and business management software consulting. We also intend to add additional services to the ones that we currently offer, including systems integration, accredited partnership services, and installation and resale of third parties systems and software. We intend to accomplish this by entering into new cooperative agreements or acquiring other existing companies although there can be no assurance we will do so. We anticipate that we will spend approximately $15,000 to evaluate the different methods of adding services. This cost is made of up primarily legal, planning and structuring, and accounting due diligence. We currently have no binding agreements, commitments or contracts for new cooperative agreements or acquisition of other existing companies or any new customer engagements.

 

In addition to adding services we also plan to evaluate offering our services to different geographical markets. We have historically focused our services on customers in Europe. We plan on expanding our geographical reach to: United Arab Emirates, Jordan, Malta, Lebanon, Algeria, and Saudi Arabia. Some of the methods we intend to use to accomplish this are: marketing our services through the internet to new geographic areas, creating strategic relationships with companies in the new geographical regions, and possibly acquiring companies that operate in different geographical regions although there can be no assurance we will do so. We anticipate that we will spend $15,000 evaluating the different methods and regions we plan on expanding to. This cost is made of up primarily legal, planning and structuring, and accounting due diligence. We currently have no binding agreements, commitments or contracts in any different geographical markets including United Arab Emirates, Jordan, Malta, Lebanon, Algeria, and Saudi Arabia or in Europe.

 

We plan to continue our efforts to collect the amounts we have invoiced our customers. As of September 30, 2014, our uncollected invoiced amounts were €48,900 or approximately $62,030.

 

Liquidity and Capital Resources

 

As of September 30, 2014, we had $84,425 of cash and a working capital of $5,694,813.

 

We believe that our current cash in our bank account and working capital as of September 30, 2014 will satisfy our estimated operating cash requirements for the next twelve months. The costs we anticipate incurring in the next 12 months irrespective of business development activities, including costs associated with meeting SEC requirements for staying public, are estimated to be less than $300,000.

 

We have salaries payable, resulting from accrued but unpaid compensation, due to Messrs. Mavrogiannis and Drakopoulos in the amounts totaling $76,592 and $102,500 respectively. We also have a $165,000 liability resulting from costs accrued with respects to an agreement with Green Era Ltd., in which our previous CEO and director Mr. Panagiotis Drakopoulos is a shareholder.

 

 
5

  

From September 27, 2013 through September 30, 2014 we have issued invoices to our clients for the total amount of €6,427,947 or approximately $8,771,000. From September 27, 2013 through September 30, 2014, we collected €6,379,047 on these invoices, or approximately $8,630,948. On October 15, 2014 we collected the remaining €48,900 or approximately $62,030 from our clients and have included this amount as revenue and accounts receivable on our financial statements, as the requirements to recognize this amount as revenue have been satisfied in the quarter ended September 30, 2014. Prior to the collection of the €48,900 the Company did not recognize the amount as revenue and accounts receivable on our financial statements because the collectability criteria under GAAP had not been met prior the collection of the full amount in the quarter ended September 30, 2014.

 

Revenue Recognition

 

We consider revenue recognizable when persuasive evidence of an arrangement exists, the price is fixed or determinable, goods or services have been delivered, and collectability is reasonably assured. These criteria are assumed to have been met if a customer orders an item, the goods or services have been shipped or delivered to the customer, and we have sufficient evidence of collectability, such a payment history with the customer. Revenue that is billed and received in advance such as recurring weekly or monthly services are initially deferred and recognized as revenue over the period the services are provided.

 

Our records at September 30, 2014 have been sufficient to satisfy all of the four requirements. Revenue has been recognized for the all amounts billed prior to September 30, 2014, all of which were in respect of services rendered during or prior to July 2013.

 

Off Balance Sheet Arrangements

 

As of September 30, 2014, there were no off balance sheet arrangements.

 

Critical Accounting Policies

 

Foreign Currency. We require translation of the Amplerissimo financial statements from euros to dollars since the reverse take-over on September 27, 2013. Assets and liabilities of all foreign operations are translated at year-end rates of exchange, and the statements of operations are translated at the average rates of exchange for the year. Gains or losses resulting from translating foreign currency financial statements are accumulated in a separate component of stockholders’ equity until the entity is sold or substantially liquidated. Gains or losses from foreign currency transactions (transactions denominated in a currency other than the entity’s local currency) are included in net (loss) earnings.

 

Income Taxes. We provide for income taxes in accordance with ASC Topic 740 (ASC 740). Income taxes are accounted for under the asset and liability method with deferred tax assets and liabilities recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be reversed or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in operations in the period that includes the enactment date. Deferred tax assets are reduced by a valuation allowance for the amounts of any tax benefits which, more likely than not, will not be realized.

 

 
6

  

We are liable for income taxes in the Republic of Cyprus due to our operating subsidiary Amplerissimo. The statutory corporate income tax rate in Cyprus is 12.5% and tax losses are carried forward indefinitely subject to certain rules regarding change of ownership of a company. Therefore, we have calculated potential benefits of income tax losses, subject to the restrictions below.

 

Future tax benefits of net operating loss carryforwards generated in the U.S. by us represent the primary component of our deferred tax assets. Under ASC 740 “Accounting for Income Taxes”, we evaluate at every reporting period whether the benefit of such losses will more likely than not be realized. Based on our history of taxable losses in the U.S. and the potential annual limitation on future utilization if it is determined that a change in ownership as defined in IRC 382 has occurred, we have determined that it is not more likely than not that the tax benefit of such losses will be realized prior to their expiration and thus has recorded a full valuation allowance against their net deferred tax assets.

 

Recently Issued Accounting Pronouncements

 

In July 2013, the FASB issued ASU 2013-11, “Income Taxes (Topic 740): Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carry-forward, a Similar Tax Loss, or a Tax Credit Carry-forward Exists” (a consensus of the FASB Emerging Issues Task Force). As a result of applying this ASU, an unrecognized tax benefit should be presented as a reduction of a deferred tax asset for a net operating loss (NOL) or other tax credit carry-forward when settlement in this manner is available under the tax law. The assessment of whether settlement is available under the tax law would be based on facts and circumstances as of the balance sheet reporting date and would not consider future events (e.g., upcoming expiration of related NOL carry-forwards). This classification should not affect an entity’s analysis of the realization of its deferred tax assets. Gross presentation in the rollforward of unrecognized tax positions in the notes to the financial statements would still be required. However, since the IRC Section 382 limits the amount of net operating loss carry-forwards that can be utilized upon a change in control, we have eliminated the deferred tax asset and related valuation allowance. Therefore, the adoption of ASU 2013 11 is not expected to have a material impact on our financial position or results of operations.

 

In May 2014, the FASB issued ASU 2014-09, “Revenue from Contracts with Customers,” (“ASU 2014-09”). ASU 2014-09 outlines a new, single comprehensive model for entities to use in accounting for revenue arising from contracts with customers and supersedes most current revenue recognition guidance, including industry-specific guidance. This new revenue recognition model provides a five-step analysis in determining when and how revenue is recognized. The new model will require revenue recognition to depict the transfer of promised goods or services to customers in an amount that reflects the consideration a company expects to receive in exchange for those goods or services. ASU 2014-09 is effective for reporting periods beginning after December 15, 2016, and early adoption is not permitted. We are evaluating the impact that adoption of this guidance will have on the determination or reporting of its financial results.

 

In June 2014, the FASB issued ASU 2014-12, “Accounting for Share-Based Payments When the Terms of an Award Provide that a Performance Target Could be Achieved after the Requisite Service Period,” (“ASU 2014-12”). ASU 2014-12 requires that a performance target that affects vesting, and that could be achieved after the requisite service period, be treated as a performance condition. As such, the performance target should not be reflected in estimating the grant date fair value of the award. ASU 2014-12 is effective for reporting periods beginning after December 15, 2015. Early adoption is permitted. Adoption of this guidance is not expected to have a significant impact on the determination or reporting of our financial results.

 

 
7

  

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURE ABOUT MARKET RISK
 

Not applicable.

 

ITEM 4. CONTROLS AND PROCEDURES.
 

Disclosure Controls and Procedures. Our senior management is responsible for establishing and maintaining disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d – 15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), designed to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the Securities and Exchange Commission’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by an issuer in the reports that it files or submits under the Exchange Act is accumulated and communicated to the issuer’s management, including its principal executive officer or officers and principal financial officer or officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.

 

Evaluation of Disclosure Controls and Procedures. We have evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) as of the end of the period covered by this report, with the participation of our Chief Executive Officer and Chief Financial Officer, as well as other key members of our management. Based on this evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were effective as of September 30, 2014.

 

Internal Controls Over Financial Reporting. No change occurred in our internal control over financial reporting during the third quarter of 2014 that materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

 

 
8

 

PART II — OTHER INFORMATION 

 

ITEM 1. LEGAL PROCEEDINGS.

 

None.

 

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.

 

None

 

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

 

None.

 

ITEM 4. MINE SAFETY DISCLOSURES.

 

None. 

 

ITEM 5. OTHER INFORMATION.

 

None.

 

 
9

 

ITEM 6. EXHIBITS.

 

(a) Exhibits.

 

Exhibit No.

 

Document Description

 

 

2.1

 

Share Purchase Agreement dated as of August 19, 2014 among Amplerissimo Ltd., B2IN S.A., Unilog Logistics S.A., and Wilot Limited (incorporated by reference from Exhibit 2.1 of Cosmos Holdings Inc.’s Current Report of Form 8-K filed on August 20, 2014)*

 

 

10.1 

Agreement dated as of November 12, 2014 between Amplerissimo Ltd. and Wilot Limited

 

 

31.1

 

Certification of CEO/CFO pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

     

32.1

 

Certification of CEO/CFO pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

 

101.INS

 

XBRL Instance Document

     

101.SCH

 

XBRL Taxonomy Extension Schema Document

     

101.CAL

 

XBRL Taxonomy Extension Calculation Linkbase Document

     

101.DEF

 

XBRL Taxonomy Extension Definition Linkbase Document

     

101.LAB

 

XBRL Taxonomy Extension Label Linkbase Document

     

101.PRE

 

XBRL Taxonomy Extension Presentation Linkbase Document

________________

* Previously Filed

 

 
10

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

 

Cosmos Holdings Inc.

 
       

Date: November 13, 2014

By:

/s/ Dimitrios Goulielmos

 
   

Dimitrios Goulielmos

 
   

Principal Executive Officer, 
Acting Principal Financial Officer and
Acting Principal Accounting Officer and Director

 

 

 
11

 

EXHIBIT INDEX

 

Exhibit No.

 

Document Description

     

2.1

 

Share Purchase Agreement dated as of August 19, 2014 among Amplerissimo Ltd., B2IN S.A., Unilog Logistics S.A., and Wilot Limited (incorporated by reference from Exhibit 2.1 of Cosmos Holdings Inc.’s Current Report of Form 8-K filed on August 20, 2014)*

 

 

10.1

Agreement dated as of November 12, 2014 between Amplerissimo Ltd. and Wilot Limited 

     

31.1

 

Certification of CEO/CFO pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

     

32.1

 

Certification of CEO/CFO pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

 

101.INS

 

XBRL Instance Document

     

101.SCH

 

XBRL Taxonomy Extension Schema Document

     

101.CAL

 

XBRL Taxonomy Extension Calculation Linkbase Document

     

101.DEF

 

XBRL Taxonomy Extension Definition Linkbase Document

     

101.LAB

 

XBRL Taxonomy Extension Label Linkbase Document

     

101.PRE

 

XBRL Taxonomy Extension Presentation Linkbase Document

________________

* Previously Filed

 

12